References
Chapter 1
Herrera, Blanca M, Sarah Keildson, and Cecilia M Lindgren. “Genetics and epigenetics of obesity.” Maturitas 69.1 (2011): 41-49.
Campión, Javier, Fermin Milagro, and JA Martinez. “Epigenetics and obesity.” Progress in molecular biology and translational science 94 (2009): 291-347.
Franks, Paul W, and Charlotte Ling. “Epigenetics and obesity: the devil is in the details.” BMC medicine 8.1 (2010): 88.
Bell, Christopher G, Andrew J Walley, and Philippe Froguel. “The genetics of human obesity.” Nature Reviews Genetics 6.3 (2005): 221-234.
Bays, Harold E. ““Sick fat,” metabolic disease, and atherosclerosis.” The American journal of medicine 122.1 (2009): S26-S37.
Bays, Harold E. “Adiposopathy: is “sick fat” a cardiovascular disease?.” Journal of the American College of Cardiology 57.25 (2011): 2461-2473.
Bays, Harold E et al. “Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association.” Journal of clinical lipidology 7.4 (2013): 304-383.
Avena, Nicole M, and Mark S Gold. “Variety and hyperpalatability: are they promoting addictive overeating?.” The American journal of clinical nutrition 94.2 (2011): 367-368.
Rogers, Peter J. “Obesity–is food addiction to blame?.” Addiction 106.7 (2011): 1213-1214.
Tilg, Herbert, and Arthur Kaser. “Gut microbiome, obesity, and metabolic dysfunction.” The Journal of clinical investigation 121.6 (2011): 2126.
Turnbaugh, Peter J, and Jeffrey I Gordon. “The core gut microbiome, energy balance and obesity.” The Journal of physiology 587.17 (2009): 4153-4158.
van der Klaauw, Agatha A, and I Sadaf Farooqi. “The Hunger Genes: Pathways to Obesity.” Cell 161.1 (2015): 119-132.
Volkow, Nora D, Gene-Jack Wang, and Ruben D Baler. “Reward, dopamine and the control of food intake: implications for obesity.” Trends in cognitive sciences 15.1 (2011): 37-46.
Meule, Adrian, Joachim Westenhöfer, and Andrea Kübler. “Food cravings mediate the relationship between rigid, but not flexible control of eating behavior and dieting success.” Appetite 57.3 (2011): 582-584.
Westenhoefer, Joachim, Albert J Stunkard, and Volker Pudel. “Validation of the flexible and rigid control dimensions of dietary restraint.” International Journal of Eating Disorders 26.1 (1999): 53-64.
Jensen, Michael D et al. “2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society.” Journal of the American College of Cardiology 63.25_PA (2014): 2985-3023.
Gregg, Edward W et al. “Association of an intensive lifestyle intervention with remission of type 2 diabetes.” Jama 308.23 (2012): 2489-2496.
Wing, Rena R et al. “Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes.” Diabetes care 34.7 (2011): 1481-1486.
Greenway, FL. “Physiological adaptations to weight loss and factors favouring weight regain.” International Journal of Obesity (2015).
Chapter 2
Jensen, Michael D et al. “2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society.” Journal of the American College of Cardiology 63.25_PA (2014): 2985-3023.
Robinson, Eric et al. “A systematic review and meta-analysis examining the effect of eating rate on energy intake and hunger.” The American journal of clinical nutrition (2014): ajcn. 081745.
Fukkoshi, Yuko, Rie Akamatsu, and Misa Shimpo. “The relationship of eating until 80% full with types and energy values of food consumed.” Eating behaviors 17 (2015): 153-156.
Hu, Tian et al. “Effects of low-carbohydrate diets versus low-fat diets on metabolic risk factors: a meta-analysis of randomized controlled clinical trials.” American journal of epidemiology 176.suppl 7 (2012): S44-S54.
Gardner, Christopher D et al. “Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial.” Jama 297.9 (2007): 969-977.
Johnston, Bradley C et al. “Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis.” Jama 312.9 (2014): 923-933.
Yancy, William S et al. “Effect of allowing choice of diet on weight loss: a randomized trial.” Annals of internal medicine 162.12 (2015): 805-814.
Perri, Michael G. “Effects of behavioral treatment on long‐term weight loss: Lessons learned from the look AHEAD trial.” Obesity 22.1 (2014): 3-4.
Look AHEAD Research Group. “Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study.” Obesity (Silver Spring, Md.) 22.1 (2014): 5-13.
Bond, Dale S et al. “Weight-loss maintenance in successful weight losers: surgical vs non-surgical methods.” International Journal of Obesity 33.1 (2009): 173-180.
Klempel, Monica C et al. “Intermittent fasting combined with calorie restriction is effective for weight loss and cardio-protection in obese women.” Nutr J 11.98 (2012): 4.
Johnstone, Alexandra M et al. “Effects of a high-protein ketogenic diet on hunger, appetite, and weight loss in obese men feeding ad libitum.” The American journal of clinical nutrition 87.1 (2008): 44-55.
Keogh, JB, and PM Clifton. “The role of meal replacements in obesity treatment.” Obesity reviews 6.3 (2005): 229-234.
Jakicic, John M. “The effect of physical activity on body weight.” Obesity 17.S3 (2009): S34-S38.
Jakicic, John M, and Amy D Otto. “Physical activity considerations for the treatment and prevention of obesity.” The American journal of clinical nutrition 82.1 (2005): 226S-229S.
Mekary, Rania A et al. “Weight training, aerobic physical activities, and long‐term waist circumference change in men.” Obesity 23.2 (2015): 461-467.
Willis, Leslie H et al. “Effects of aerobic and/or resistance training on body mass and fat mass in overweight or obese adults.” Journal of Applied Physiology 113.12 (2012): 1831-1837.
Slentz, Cris A et al. “Effects of the amount of exercise on body weight, body composition, and measures of central obesity: STRRIDE—a randomized controlled study.” Archives of internal medicine 164.1 (2004): 31-39.
Villablanca, Pedro A et al. “Nonexercise Activity Thermogenesis in Obesity Management.” Mayo Clinic Proceedings 30 Apr. 2015: 509-519.
Di Milia, Lee, Corneel Vandelanotte, and Mitch J Duncan. “The association between short sleep and obesity after controlling for demographic, lifestyle, work and health related factors.” Sleep medicine 14.4 (2013): 319-323.
Antunes, LC et al. “Obesity and shift work: chronobiological aspects.” Nutrition research reviews 23.01 (2010): 155-168.
Chirinos, Julio A et al. “CPAP, weight loss, or both for obstructive sleep apnea.” New England Journal of Medicine 370.24 (2014): 2265-2275.
Redenius, Rachel et al. “Does CPAP lead to change in BMI?.” Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine 4.3 (2008): 205.
Force, Adult Obstructive Sleep Apnea Task, and American Academy of Sleep Medicine. “Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults.” Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine 5.3 (2009): 263.
Buscemi, Nina et al. “Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis.” Bmj 332.7538 (2006): 385-393.
Steinberg, Dori M et al. “Weighing Every Day Matters: Daily Weighing Improves Weight Loss and Adoption of Weight Control Behaviors.” Journal of the Academy of Nutrition and Dietetics 115.4 (2015): 511-518.
Steinberg, Dori M et al. “Daily self-weighing and adverse psychological outcomes: a randomized controlled trial.” American journal of preventive medicine 46.1 (2014): 24-29.
Casazza, Krista et al. “Myths, presumptions, and facts about obesity.” New England Journal of Medicine 368.5 (2013): 446-454.
Hwang, Kevin O et al. “Social support in an Internet weight loss community.” International journal of medical informatics 79.1 (2010): 5-13.
Wieland, L Susan et al. “Interactive computer-based interventions for weight loss or weight maintenance in overweight or obese people.” Cochrane Database Syst Rev 8.8 (2012).
Chapter 3
Knudsen, Nils et al. “Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population.” The Journal of Clinical Endocrinology & Metabolism 90.7 (2005): 4019-4024.
Reinehr, Thomas. “Obesity and thyroid function.” Molecular and cellular endocrinology 316.2 (2010): 165-171.
Nyrnes, A, R Jorde, and J Sundsfjord. “Serum TSH is positively associated with BMI.” International journal of obesity 30.1 (2006): 100-105.
Manji, N et al. “Lack of association between serum TSH or free T4 and body mass index in euthyroid subjects.” Clinical endocrinology 64.2 (2006): 125-128.
Fox, Caroline S et al. “Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample.” Archives of Internal Medicine 168.6 (2008): 587-592.
Hoang, Thanh D et al. “Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study.” (2013).
Celi, Francesco S et al. “Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine.” The Journal of Clinical Endocrinology & Metabolism 96.11 (2011): 3466-3474.
Escobar-Morreale, Héctor F et al. “Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone.” Annals of internal medicine 142.6 (2005): 412-424.
Nieman, Lynnette K et al. “The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline.” The Journal of Clinical Endocrinology & Metabolism 93.5 (2008): 1526-1540.
Wajchenberg, BL et al. “Estimation of body fat and lean tissue distribution by dual energy X-ray absorptiometry and abdominal body fat evaluation by computed tomography in Cushing’s disease.” The Journal of Clinical Endocrinology & Metabolism 80.9 (1995): 2791-2794.
Stanworth, R, and T Jones. “Testosterone in obesity, metabolic syndrome and type 2 diabetes.” 37 (2009): 74-90.
Saad, F et al. “Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity Classes I-III: Observational data from two registry studies.” International journal of obesity (2005) (2015).
Saad, Farid et al. “Long‐term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss.” Obesity 21.10 (2013): 1975-1981.
Kelly, DM, and TH Jones. “Testosterone and obesity.” Obesity Reviews (2015).
ESHRE, The Rotterdam, and ASRM-Sponsored PCOS Consensus Workshop Group. “Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.” Fertility and sterility 81.1 (2004): 19-25.
Pasquali, Renato et al. “Heterogeneity in the responsiveness to long-term lifestyle intervention and predictability in obese women with polycystic ovary syndrome.” European Journal of Endocrinology 164.1 (2011): 53-60.
Domecq, Juan Pablo et al. “Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis.” The Journal of Clinical Endocrinology & Metabolism 98.12 (2013): 4655-4663.
Wei, Wei et al. “A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome.” European Journal of Endocrinology 166.1 (2012): 99-105.
Beatriz Motta, Alicia. “The role of obesity in the development of polycystic ovary syndrome.” Current pharmaceutical design 18.17 (2012): 2482-2491.
Sørensen, Lone B et al. “Effects of increased dietary protein-to-carbohydrate ratios in women with polycystic ovary syndrome.” The American journal of clinical nutrition 95.1 (2012): 39-48.
Ravn, P, AG Haugen, and D Glintborg. “Overweight in polycystic ovary syndrome. An update on evidence based advice on diet, exercise and metformin use for weight loss.” Minerva Endocrinol 38.1 (2013): 59-76.
Gower, Barbara A et al. “Favourable metabolic effects of a eucaloric lower‐carbohydrate diet in women with PCOS.” Clinical endocrinology 79.4 (2013): 550-557.
De Zwaan, M. “Binge eating disorder and obesity.” International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity 25 (2001): S51-5.
Claudino, Angelica M et al. “Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder.” The Journal of clinical psychiatry 68.9 (2007): 1324-1332.
Reas, Deborah L, and Carlos M Grilo. “Review and Meta‐analysis of Pharmacotherapy for Binge‐eating Disorder.” Obesity 16.9 (2008): 2024-2038.
Al-Safi, Zain A, and Alex J Polotsky. “Obesity and Menopause.” Best Practice & Research Clinical Obstetrics & Gynaecology 29.4 (2015): 548-553.
Mastorakos, G et al. “Management of obesity in menopause: Diet, exercise, pharmacotherapy and bariatric surgery.” Maturitas 65.3 (2010): 219-224.
Lizcano, Fernando, and Guillermo Guzmán. “Estrogen deficiency and the origin of obesity during menopause.” BioMed research international 2014 (2014).
Farooqi, I Sadaf, and Stephen O’Rahilly. “Monogenic obesity in humans.” Annu. Rev. Med. 56 (2005): 443-458.
Dubern, Beatrice, and Karine Clement. “Leptin and leptin receptor-related monogenic obesity.” Biochimie 94.10 (2012): 2111-2115.
Hinney, Anke, Carla IG Vogel, and Johannes Hebebrand. “From monogenic to polygenic obesity: recent advances.” European child & adolescent psychiatry 19.3 (2010): 297-310.Hinney, Anke, and Johannes Hebebrand. “Polygenic obesity in humans.” Obesity Facts 1.1 (2008): 35-42.
Lee, Michelle, and Judith Korner. “Review of physiology, clinical manifestations, and management of hypothalamic obesity in humans.” Pituitary 12.2 (2009): 87-95.
Bereket, A et al. “Hypothalamic obesity in children.” Obesity Reviews 13.9 (2012): 780-798.
Domecq, Juan Pablo et al. “Drugs commonly associated with weight change: a systematic review and meta-analysis.” The Journal of Clinical Endocrinology & Metabolism 100.2 (2015): 363-370.
Ness-Abramof, Rosane, and Caroline M Apovian. “Drug-induced weight gain.” Drugs of today 41.8 (2005): 547.
Camelia Davtyan, MD, and Mina Ma. “Drug-induced weight gain.” Proceedings of UCLA Healthcare 12 (2008).
Apovian, Caroline M et al. “Pharmacological management of obesity: an endocrine society clinical practice guideline.” The Journal of Clinical Endocrinology & Metabolism (2015).
Seger JC, Horn DB, Westman EC, Primack C, Schmidt SL, Ravasia D, McCarthy W, Ferguson U, Sabowitz BN, Scinta W, Bays HE. Obesity Algorithm, presented by the American Society of Bariatric Physicians, 2014-2015. www.obesityalgorithm.org. (Access = Aug 2015)
Allison, David B et al. “Controlled‐Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP).” Obesity 20.2 (2012): 330-342.
Garvey, W Timothy et al. “Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study.” The American journal of clinical nutrition 95.2 (2012): 297-308.
Bays, Harold. “Phentermine, topiramate and their combination for the treatment of adiposopathy (‘sick fat’) and metabolic disease.” 8.12 (2010): 1777-1801.
Fleming, Joshua W, Katie S McClendon, and Daniel M Riche. “New obesity agents: lorcaserin and phentermine/topiramate.” Annals of Pharmacotherapy 47.7-8 (2013): 1007-1016.
Cameron, Fiona, Glenn Whiteside, and Kate McKeage. “Phentermine and Topiramate Extended Release (Qsymia™).” Drugs 72.15 (2012): 2033-2042.
Smith, Steven M, Melissa Meyer, and Katy E Trinkley. “Phentermine/topiramate for the treatment of obesity.” Annals of Pharmacotherapy 47.3 (2013): 340-349.
Colman, Eric et al. “The FDA’s assessment of two drugs for chronic weight management.” New England Journal of Medicine 367.17 (2012): 1577-1579.
Smith, Steven R et al. “Multicenter, placebo-controlled trial of lorcaserin for weight management.” New England Journal of Medicine 363.3 (2010): 245-256.
O’neil, Patrick M et al. “Randomized Placebo‐Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM‐DM Study.” Obesity 20.7 (2012): 1426-1436.
Fidler, Meredith C et al. “A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial.” The Journal of Clinical Endocrinology & Metabolism 96.10 (2011): 3067-3077.
Greenway, Frank L et al. “Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.” The Lancet 376.9741 (2010): 595-605.
Sinnayah, Puspha et al. “Bupropion and naltrexone interact synergistically to decrease food intake in mice.” North American association for the study of obesity annual scientific meeting, New Orleans, LA Oct. 2007.
Clapper, Jason R et al. “Effects of amylin and bupropion/naltrexone on food intake and body weight are interactive in rodent models.” European journal of pharmacology 698.1 (2013): 292-298.
Wadden, Thomas A et al. “Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR‐BMOD Trial.” Obesity 19.1 (2011): 110-120.
Halpern, B, AM Faria, and A Halpern. “Bupropion/naltrexone fixed-dose combination for the treatment of obesity.” Drugs Today (Barc) 47.8 (2011): 575-581.
Greenway, Frank L et al. “Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.” The Lancet 376.9741 (2010): 595-605.
Apovian, Caroline M et al. “A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II).” Obesity 21.5 (2013): 935-943.
Hollander, Priscilla et al. “Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes.” Diabetes care 36.12 (2013): 4022-4029.
Wadden, Thomas A et al. “Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study.” International journal of obesity 37.11 (2013): 1443-1451.
Pi-Sunyer, Xavier et al. “A randomized, controlled trial of 3.0 mg of Liraglutide in weight management.” New England Journal of Medicine 373.1 (2015): 11-22.
Vilsbøll, Tina et al. “Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials.” Bmj 344 (2012): d7771.
Longitudinal Assessment of Bariatric Surgery (LABS) Consortium. “Peri-operative safety in the longitudinal assessment of bariatric surgery.” The New England journal of medicine 361.5 (2009): 445.
Sjöström, Lars et al. “Effects of bariatric surgery on mortality in Swedish obese subjects.” New England journal of medicine 357.8 (2007): 741-752.
Puzziferri, Nancy et al. “Long-term follow-up after bariatric surgery: a systematic review.” Jama 312.9 (2014): 934-942.
Ikramuddin, Sayeed et al. “Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial.” JAMA 312.9 (2014): 915-922.
Ponce, Jaime et al. “The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity.” Surgery for Obesity and Related Diseases (2014).
Frestedt, Joy L et al. “A whey-protein supplement increases fat loss and spares lean muscle in obese subjects: a randomized human clinical study.” Nutr Metab (Lond) 5.1 (2008): 8.
Belobrajdic, Damien P, Graeme H McIntosh, and Julie A Owens. “A high-whey-protein diet reduces body weight gain and alters insulin sensitivity relative to red meat in wistar rats.” The Journal of nutrition 134.6 (2004): 1454-1458.
Pal, Sebely et al. “Comparative effects of whey and casein proteins on satiety in overweight and obese individuals: a randomized controlled trial.” European journal of clinical nutrition 68.9 (2014): 980-986.
Pal, Sebely, Vanessa Ellis, and Satvinder Dhaliwal. “Effects of whey protein isolate on body composition, lipids, insulin and glucose in overweight and obese individuals.” British journal of nutrition 104.05 (2010): 716-723.
Noakes, Manny et al. “Meal replacements are as effective as structured weight-loss diets for treating obesity in adults with features of metabolic syndrome.” The Journal of nutrition 134.8 (2004): 1894-1899.
Li, Z et al. “Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein.” European Journal of Clinical Nutrition 59.3 (2005): 411-418.
Zhang, Zhiguo et al. “Berberine activates thermogenesis in white and brown adipose tissue.” Nature communications 5 (2014).
Zhang, Hao et al. “Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.” Metabolism 59.2 (2010): 285-292.
Zhang, Yifei et al. “Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine.” The Journal of Clinical Endocrinology & Metabolism 93.7 (2008): 2559-2565.
Dong, Hui et al. “Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis.” Evidence-Based Complementary and Alternative Medicine 2012 (2012).
Bemben, Michael G, and Hugh S Lamont. “Creatine supplementation and exercise performance.” Sports Medicine 35.2 (2005): 107-125.
Gualano, Bruno et al. “Creatine in type 2 diabetes: a randomized, double-blind, placebo-controlled trial.” Med Sci Sports Exerc 43.5 (2011): 770-778.
Ding, Ming et al. “Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis.” Diabetes care 37.2 (2014): 569-586.
Acheson, KJ et al. “Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals.” The American journal of clinical nutrition 33.5 (1980): 989-997.
Holick, Michael F. “Vitamin D deficiency.” New England Journal of Medicine 357.3 (2007): 266-281.
Holick, Michael F et al. “Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.” The Journal of Clinical Endocrinology & Metabolism 96.7 (2011): 1911-1930.
Vimaleswaran, Karani S et al. “Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts.” PLoS Med 10.2 (2013): e1001383.
Shiraki, Masataka et al. “Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis.” Journal of bone and mineral research 15.3 (2000): 515-521.
Geleijnse, Johanna M et al. “Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study.” The Journal of nutrition 134.11 (2004): 3100-3105.
Knapen, MHJ et al. “Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women.” Thromb Haemost 113.5 (2015): 1135-1144.
Beulens, Joline WJ et al. “The role of menaquinones (vitamin K 2) in human health.” British Journal of Nutrition 110.08 (2013): 1357-1368.
Harris, William S, and Clemens von Schacky. “The Omega-3 Index: a new risk factor for death from coronary heart disease?.” Preventive medicine 39.1 (2004): 212-220.
Harris, William S. “Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor.” Pharmacological Research 55.3 (2007): 217-223.
Harris, William S. “The omega-3 index as a risk factor for coronary heart disease.” The American journal of clinical nutrition 87.6 (2008): 1997S-2002S.
Wang, Qianqian et al. “Effect of omega-3 fatty acids supplementation on endothelial function: a meta-analysis of randomized controlled trials.” Atherosclerosis 221.2 (2012): 536-543.
Wei, Melissa Y, and Terry A Jacobson. “Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: a systematic review and meta-analysis.” Current atherosclerosis reports 13.6 (2011): 474-483.
Mozaffarian, Dariush et al. “Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study.” Annals of internal medicine 158.7 (2013): 515-525.
Park, Sunmin, and Ji-Hyun Bae. “Probiotics for Weight Loss: A Systematic Review and Meta-Analysis.” Nutrition Research (2015).
Khalesi, Saman et al. “Effect of probiotics on blood pressure a systematic review and meta-analysis of randomized, controlled trials.” Hypertension 64.4 (2014): 897-903.
Egras, Amy M et al. “An evidence-based review of fat modifying supplemental weight loss products.” Journal of obesity 2011 (2010).
Frequently Asked Questions
Miller, Paige E, and Vanessa Perez. “Low-calorie sweeteners and body weight and composition: a meta-analysis of randomized controlled trials and prospective cohort studies.” The American journal of clinical nutrition 100.3 (2014): 765-777.
Li, Duo et al. “Lean meat and heart health.” Asia Pacific journal of clinical nutrition 14.2 (2005): 113-119.
Micha, Renata, Sarah K Wallace, and Dariush Mozaffarian. “Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus a systematic review and meta-analysis.” Circulation 121.21 (2010): 2271-2283.
Mozaffarian, Dariush, Renata Micha, and Sarah Wallace. “Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials.” PLoS medicine 7.3 (2010): 332.
Berger, Samantha et al. “Dietary cholesterol and cardiovascular disease: a systematic review and meta-analysis.” The American journal of clinical nutrition (2015): ajcn100305.
Hooper, Lee et al. “Reduction in saturated fat intake for cardiovascular disease.” The Cochrane Library (2015).